Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population

被引:72
作者
Hiratsuka, M [1 ]
Inoue, T [1 ]
Omori, F [1 ]
Agatsuma, Y [1 ]
Mizugaki, M [1 ]
机构
[1] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
thiopurine methyltransferase; pharmacogenetics; genetic polymorphism;
D O I
10.1016/S0027-5107(00)00004-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs such as 6-mercaptopurine, B-thioguanine, and azathiopurine. Several mutations in the TPMT gene have been identified which correlate with a low activity phenotype. The molecular basis for the genetic polymorphism of TPMT has been established for European Caucasians, African-Americans, Southwest Asians and Chinese, but it remains to be elucidated in Japanese populations. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A (G460A and A719G), TPMT*3B (G460A) and TPMT*3C (A719G) were determined in Japanese samples (n=192) using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. TPMT*3C was found in 0.8% of the samples (three heterozygotes). The TPMT*2, TPMT*3A and TPMT*3B alleles were not detected in any of the samples analyzed. This study provides the first analysis of TPMT mutant allele frequency in a sample of Japanese population and indicates that TPMT*3C is the most common allele in Japanese subjects. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 23 条
  • [1] Thiopurine methyltransferase alleles in British and Ghanaian populations
    Ameyaw, MM
    Collie-Duguid, ESR
    Powrie, RH
    Ofori-Adjei, D
    McLeod, HL
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (02) : 367 - 370
  • [2] ETHNIC AND GEOGRAPHIC PERSPECTIVES IN SLE
    CITERA, G
    WILSON, WA
    [J]. LUPUS, 1993, 2 (06) : 351 - 353
  • [3] The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
    Collie-Duguid, ESR
    Pritchard, SC
    Powrie, RH
    Sludden, J
    Collier, DA
    Li, T
    McLeod, HL
    [J]. PHARMACOGENETICS, 1999, 9 (01): : 37 - 42
  • [4] de la Moureyre CSV, 1998, HUM MUTAT, V12, P177, DOI 10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO
  • [5] 2-E
  • [6] PURINE SUBSTRATES FOR HUMAN THIOPURINE METHYLTRANSFERASE
    DEININGER, M
    SZUMLANSKI, CL
    OTTERNESS, DM
    VANLOON, J
    FERBER, W
    WEINSHILBOUM, RM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) : 2135 - 2138
  • [7] ESCOUSSE A, 1995, EUR J CLIN PHARMACOL, V48, P309
  • [8] Polymorphism of the thiopurine S-methyltransferase gene in African-Americans
    Hon, YY
    Fessing, MY
    Pui, CH
    Relling, MV
    Krynetski, EY
    Evans, WE
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (02) : 371 - 376
  • [9] Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms
    Krynetski, EY
    Tai, HL
    Yates, CR
    Fessing, MY
    Loennechen, T
    Schuetz, JD
    Relling, MV
    Evans, WE
    [J]. PHARMACOGENETICS, 1996, 6 (04): : 279 - 290
  • [10] A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE
    KRYNETSKI, EY
    SCHUETZ, JD
    GALPIN, AJ
    PUI, CH
    RELLING, MV
    EVANS, WE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 949 - 953